The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

Research at the University of Colorado found that 4:3 intermittent fasting resulted in greater weight loss than daily caloric restriction. Researchers discuss the findings.

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

Fact checked by Nick BlackmerA new study found that a 4:3 intermittent fasting plan—with three days of fasting per ...

The state is thinking about requiring Medicaid patients who want to use GLP-1s for weight loss to meet a certain number on the body-mass index or try diet and exercise programs or less expensive ...